title: The deadly impact of extreme drug resistance in Acinetobacter baumannii.
authors.affiliation: Division of General Internal Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; and, Division of General Internal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA Department of Medicine, Department of Pharmacology; and, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH.
authors.forename: Brad
authors.initials: B
authors.lastname: Spellberg
authors.forename: Robert A
authors.initials: RA
authors.lastname: Bonomo
mesh_terms: D000151:Acinetobacter Infections / Q000401:mortality*; D040981:Acinetobacter baumannii / Q000302:isolation & purification*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000382:microbiology*; D001426:Bacterial Proteins / Q000235:genetics*; D005260:Female; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D008297:Male; D018440:beta-Lactam Resistance / Q000235:genetics*
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D015378:Imipenem
references.citation: Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41
references.pmid: 20597669
references.citation: Microbiology (Reading). 2009 Jul;155(Pt 7):2333-2341
references.pmid: 19389786
references.citation: Clin Infect Dis. 1994 Jun;18(6):896-900
references.pmid: 8086549
references.citation: J Crit Care. 2012 Jun;27(3):322.e7-14
references.pmid: 22137378
references.citation: Emerg Infect Dis. 2009 Aug;15(8):1325-7
references.pmid: 19751609
references.citation: Infect Control Hosp Epidemiol. 2010 Oct;31(10):1057-62
references.pmid: 20715975
references.citation: Crit Care Med. 2014 May;42(5):1081-8
references.pmid: 24394630
references.citation: Am J Respir Crit Care Med. 2011 Dec 15;184(12):1409-17
references.pmid: 21920919
references.citation: J Infect. 2010 Sep;61(3):212-8
references.pmid: 20600295
references.citation: J Med Microbiol. 2011 May;60(Pt 5):605-611
references.pmid: 21233298
references.citation: Int J Antimicrob Agents. 2009 Dec;34(6):575-9
references.pmid: 19740628
references.citation: Lancet Infect Dis. 2013 Aug;13(8):665-71
references.pmid: 23622939
references.citation: Clin Microbiol Rev. 2008 Jul;21(3):538-82
references.pmid: 18625687
references.citation: Clin Microbiol Infect. 2005 Nov;11(11):868-73
references.pmid: 16216100
references.citation: Medicine (Baltimore). 1977 Mar;56(2):79-97
references.pmid: 846390
references.citation: Scand J Infect Dis. 2010 Oct;42(10):741-6
references.pmid: 20500117
references.citation: N Engl J Med. 2013 Jan 24;368(4):299-302
references.pmid: 23343059
references.citation: Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S150-70
references.pmid: 20597666
references.citation: Clin Microbiol Infect. 2014 May;20(5):416-23
references.pmid: 24131374
references.citation: JAMA. 2009 Dec 2;302(21):2323-9
references.pmid: 19952319
references.citation: J Antimicrob Chemother. 2007 Mar;59(3):525-30
references.pmid: 17213265
references.citation: Antimicrob Agents Chemother. 2013 Oct;57(10):4605-7
references.pmid: 23896479
references.citation: Medicine (Baltimore). 1995 Nov;74(6):340-9
references.pmid: 7500897
references.citation: J Microbiol Immunol Infect. 2012 Oct;45(5):356-62
references.pmid: 22575430
references.citation: Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9
references.pmid: 21825287